Cohort Study on Refractive Errors in Preschool Children (PREC)
Refractive error is a common visual disorder encompassing myopia, hyperopia, astigmatism and other subtypes. Refractive error in preschool children refers to refractive abnormalities occurring during the preschool period (0-6 years old). Studies conducted across diverse regions and populations report that the prevalence of refractive error among preschool children ranges approximately from 10% to 30%, with this proportion showing a gradual upward trend in recent years. Existing evidence suggests that preschool refractive status is correlated with multiple ocular and systemic diseases. Furthermore, the preschool years represent a highly sensitive window for children's visual development; uncorrected refractive errors at this stage can disrupt visual maturation and induce permanent visual impairment. Accordingly, identifying the full spectrum of comorbidities associated with preschool refractive error, alongside implementing early diagnosis and intervention, is clinically critical.
Nevertheless, substantial challenges persist in the clinical management of preschool refractive errors: the complete comorbidity spectrum remains undefined, its natural history has not been fully elucidated, and high-quality evidence-based guidelines for refractive correction and visual rehabilitation are lacking. Establishing a prospective cohort of preschool children with refractive errors is therefore of great significance for clarifying disease progression and risk factors, generating evidence for standardized refractive interventions and visual rehabilitation protocols, and ultimately preventing visual impairment and improving quality of life in this vulnerable pediatric population.
Our research team has previously completed preliminary investigations characterizing myopia in preschoolers. Building on this foundational work, we aim to construct a dedicated cohort of preschool children with refractive errors to delineate the natural history, progression risks and comorbidity profiles of preschool refractive error, and explore effective refractive correction and visual rehabilitation approaches for affected young children.
Descripción general del estudio
Estado
Condiciones
Tipo de estudio
Inscripción (Estimado)
Contactos y Ubicaciones
Estudio Contacto
- Nombre: Xiao Yang
- Número de teléfono: 13760766303
- Correo electrónico: yangx_zoc@163.com
Ubicaciones de estudio
-
-
Guanzhou
-
Guangdong, Guanzhou, Porcelana, 510060
- Zhongshan Ophthalmic Center Sun Yat-Sen University
-
Contacto:
- Xiao Yang
- Número de teléfono: 13760766303
- Correo electrónico: yangx_zoc@163.com
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
- Niño
Acepta Voluntarios Saludables
Método de muestreo
Población de estudio
Descripción
Inclusion Criteria:
- Onset of refractive error occurs during preschool age (0-6 years old) supported by retrievable medical records;
- Spherical equivalent power ≤ -0.50 D or ≥ +3.00 D in any meridian;
- Legal guardians agree to participate and sign written informed consent.
Exclusion Criteria:
Children unable to cooperate with examinations and follow-up visits.
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
Cohortes e Intervenciones
Grupo / Cohorte |
|---|
|
Refractive error
Refractive error in preschool children
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Ocular Biometry Parameters
Periodo de tiempo: From date of enrollment until the date of loss to follow-up from any cause, whichever came first, assessed up to 36 months
|
A set of objective ocular structural measurements mainly including axial length (AL), alongside corneal curvature, anterior chamber depth, lens thickness and vitreous chamber depth.
Axial length, the core indicator in this study, refers to the linear distance from the anterior corneal surface to the retinal pigment epithelium, which is closely associated with the onset and progression of refractive errors in preschool children.
All biometric indices will be measured using standardized ophthalmic biometry equipment at each follow-up visit to dynamically observe the developmental rules of ocular dimensions and their correlation with refractive status.
|
From date of enrollment until the date of loss to follow-up from any cause, whichever came first, assessed up to 36 months
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
BCVA
Periodo de tiempo: From date of enrollment until the date of loss to follow-up from any cause, whichever came first, assessed up to 36 months
|
Visual Acuity Examination
|
From date of enrollment until the date of loss to follow-up from any cause, whichever came first, assessed up to 36 months
|
|
Contrast Sensitivity
Periodo de tiempo: From date of enrollment until the date of loss to follow-up from any cause, whichever came first, assessed up to 36 months
|
CSF
|
From date of enrollment until the date of loss to follow-up from any cause, whichever came first, assessed up to 36 months
|
|
SER
Periodo de tiempo: From date of enrollment until the date of loss to follow-up from any cause, whichever came first, assessed up to 36 months
|
Spherical Equivalent Refraction，Comprehensive index reflecting overall ocular refractive status, integrating myopia, hyperopia and astigmatism.
|
From date of enrollment until the date of loss to follow-up from any cause, whichever came first, assessed up to 36 months
|
|
WES (Whole Exome Sequencing)
Periodo de tiempo: From date of enrollment until the date of loss to follow-up from any cause, whichever came first, assessed up to 36 months
|
Genetic sequencing results of all protein-coding regions to detect gene variants related to refractive disorders.
|
From date of enrollment until the date of loss to follow-up from any cause, whichever came first, assessed up to 36 months
|
|
OCT
Periodo de tiempo: From date of enrollment until the date of loss to follow-up from any cause, whichever came first, assessed up to 36 months
|
OCT Imaging Findings
|
From date of enrollment until the date of loss to follow-up from any cause, whichever came first, assessed up to 36 months
|
Colaboradores e Investigadores
Patrocinador
Colaboradores
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Estimado)
Finalización primaria (Estimado)
Finalización del estudio (Estimado)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- 2023KYPJ340-2
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .